Loading…
Phosphatidylinositol 3-kinase coordinately activates the MEK/ERK and AKT/NFκB pathways to maintain osteoclast survival
We have examined highly purified osteoclasts that were generated in vitro from murine co‐culture of marrow precursors with stromal support cells and have found evidence of activation of the MEK/ERK and AKT/NFκB survival pathways. Many mature marrow‐derived osteoclasts survived for at least 48 h in c...
Saved in:
Published in: | Journal of cellular biochemistry 2003-05, Vol.89 (1), p.165-179 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c3363-dc03e0e708ae2f7b247909256b290dc015d019c4b5dc0036604358f38a4ac2cd3 |
---|---|
cites | cdi_FETCH-LOGICAL-c3363-dc03e0e708ae2f7b247909256b290dc015d019c4b5dc0036604358f38a4ac2cd3 |
container_end_page | 179 |
container_issue | 1 |
container_start_page | 165 |
container_title | Journal of cellular biochemistry |
container_volume | 89 |
creator | Gingery, Anne Bradley, Elizabeth Shaw, Aubie Oursler, Merry Jo |
description | We have examined highly purified osteoclasts that were generated in vitro from murine co‐culture of marrow precursors with stromal support cells and have found evidence of activation of the MEK/ERK and AKT/NFκB survival pathways. Many mature marrow‐derived osteoclasts survived for at least 48 h in culture whether or not they are maintained with stromal cells. Moreover, supplementing purified osteoclasts with RANKL and/or M‐CSF had no impact on their survival pattern. In addition, spleen‐derived osteoclasts generated with RANKL and M‐CSF treatment exhibited a similar survival pattern. Blocking MEK, AKT, or NFκB activity resulted in apoptosis of many, but not all, of the osteoclasts in purified marrow‐derived osteoclasts, marrow‐derived osteoclasts co‐cultured with stromal cells, and spleen‐derived osteoclasts maintained with RANKL and M‐CSF. These data support that both the MEK/ERK and AKT/NFκB pathways contribute to osteoclast survival. Since PI3K has been shown to activate either of these pathways, we have examined its role in osteoclast survival. PI3K inhibition caused apoptosis of nearly all osteoclasts in purified and co‐cultured marrow‐derived osteoclasts and spleen‐derived osteoclasts maintained with RANKL and M‐CSF. Interestingly, in marrow‐derived co‐cultures, the apoptotic response was restricted to osteoclasts as there was no evidence of stromal support cell apoptosis. PI3K inhibition also blocked MEK1/2, ERK1/2, and AKT phosphorylation and NFκB activation in purified osteoclasts. Simultaneous blockage of both AKT and MEK1/2 caused rapid apoptosis of nearly all osteoclasts, mimicking the response to PI3K inhibition. These data reveal that PI3K coordinately activates two distinct survival pathways that are both important in osteoclast survival. J. Cell. Biochem. 89: 165–179, 2003. © 2003 Wiley‐Liss, Inc. |
doi_str_mv | 10.1002/jcb.10503 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_19721935</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>19721935</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3363-dc03e0e708ae2f7b247909256b290dc015d019c4b5dc0036604358f38a4ac2cd3</originalsourceid><addsrcrecordid>eNp1kD1OAzEQhS0EEuGn4AaukCiWjO39iUuIkgALAaEgSsvxOorBWYe1Q9ircQjOhCFARzGaN5rvveIhdETglADQ7pOaRpEB20IdArxI0jxNt1EHCgYJZYTuoj3vnwCAc0Y7aH03d345l8FUrTW18yY4i1nybGrpNVbONVWUQdsWSxXMa5Qeh7nGN4OyO7gvsawrfFZOuuPhx_s5XsowX8s2Ig4vpKlDHOx80E5Z6QP2q-Y1htgDtDOT1uvDn72PHoaDSf8iub4dXfbPrhPFWM6SSgHToAvoSU1nxZSmBQdOs3xKOcQnySogXKXTLB7A8hxSlvVmrCdTqaiq2D463uQuG_ey0j6IhfFKWytr7VZeEF5QwlkWwZMNqBrnfaNnYtmYhWxaQUB8VStiteK72sh2N-zaWN3-D4qr_vmvI9k4TKzi7c8hm2eRF6zIxON4JHh-X_YgLwWwT2lpisA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19721935</pqid></control><display><type>article</type><title>Phosphatidylinositol 3-kinase coordinately activates the MEK/ERK and AKT/NFκB pathways to maintain osteoclast survival</title><source>Wiley</source><creator>Gingery, Anne ; Bradley, Elizabeth ; Shaw, Aubie ; Oursler, Merry Jo</creator><creatorcontrib>Gingery, Anne ; Bradley, Elizabeth ; Shaw, Aubie ; Oursler, Merry Jo</creatorcontrib><description>We have examined highly purified osteoclasts that were generated in vitro from murine co‐culture of marrow precursors with stromal support cells and have found evidence of activation of the MEK/ERK and AKT/NFκB survival pathways. Many mature marrow‐derived osteoclasts survived for at least 48 h in culture whether or not they are maintained with stromal cells. Moreover, supplementing purified osteoclasts with RANKL and/or M‐CSF had no impact on their survival pattern. In addition, spleen‐derived osteoclasts generated with RANKL and M‐CSF treatment exhibited a similar survival pattern. Blocking MEK, AKT, or NFκB activity resulted in apoptosis of many, but not all, of the osteoclasts in purified marrow‐derived osteoclasts, marrow‐derived osteoclasts co‐cultured with stromal cells, and spleen‐derived osteoclasts maintained with RANKL and M‐CSF. These data support that both the MEK/ERK and AKT/NFκB pathways contribute to osteoclast survival. Since PI3K has been shown to activate either of these pathways, we have examined its role in osteoclast survival. PI3K inhibition caused apoptosis of nearly all osteoclasts in purified and co‐cultured marrow‐derived osteoclasts and spleen‐derived osteoclasts maintained with RANKL and M‐CSF. Interestingly, in marrow‐derived co‐cultures, the apoptotic response was restricted to osteoclasts as there was no evidence of stromal support cell apoptosis. PI3K inhibition also blocked MEK1/2, ERK1/2, and AKT phosphorylation and NFκB activation in purified osteoclasts. Simultaneous blockage of both AKT and MEK1/2 caused rapid apoptosis of nearly all osteoclasts, mimicking the response to PI3K inhibition. These data reveal that PI3K coordinately activates two distinct survival pathways that are both important in osteoclast survival. J. Cell. Biochem. 89: 165–179, 2003. © 2003 Wiley‐Liss, Inc.</description><identifier>ISSN: 0730-2312</identifier><identifier>EISSN: 1097-4644</identifier><identifier>DOI: 10.1002/jcb.10503</identifier><language>eng</language><publisher>New York: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>AKT ; apoptosis ; ERK ; MEK ; NFκB ; osteoclast ; PI3K</subject><ispartof>Journal of cellular biochemistry, 2003-05, Vol.89 (1), p.165-179</ispartof><rights>Copyright © 2003 Wiley‐Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3363-dc03e0e708ae2f7b247909256b290dc015d019c4b5dc0036604358f38a4ac2cd3</citedby><cites>FETCH-LOGICAL-c3363-dc03e0e708ae2f7b247909256b290dc015d019c4b5dc0036604358f38a4ac2cd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Gingery, Anne</creatorcontrib><creatorcontrib>Bradley, Elizabeth</creatorcontrib><creatorcontrib>Shaw, Aubie</creatorcontrib><creatorcontrib>Oursler, Merry Jo</creatorcontrib><title>Phosphatidylinositol 3-kinase coordinately activates the MEK/ERK and AKT/NFκB pathways to maintain osteoclast survival</title><title>Journal of cellular biochemistry</title><addtitle>J. Cell. Biochem</addtitle><description>We have examined highly purified osteoclasts that were generated in vitro from murine co‐culture of marrow precursors with stromal support cells and have found evidence of activation of the MEK/ERK and AKT/NFκB survival pathways. Many mature marrow‐derived osteoclasts survived for at least 48 h in culture whether or not they are maintained with stromal cells. Moreover, supplementing purified osteoclasts with RANKL and/or M‐CSF had no impact on their survival pattern. In addition, spleen‐derived osteoclasts generated with RANKL and M‐CSF treatment exhibited a similar survival pattern. Blocking MEK, AKT, or NFκB activity resulted in apoptosis of many, but not all, of the osteoclasts in purified marrow‐derived osteoclasts, marrow‐derived osteoclasts co‐cultured with stromal cells, and spleen‐derived osteoclasts maintained with RANKL and M‐CSF. These data support that both the MEK/ERK and AKT/NFκB pathways contribute to osteoclast survival. Since PI3K has been shown to activate either of these pathways, we have examined its role in osteoclast survival. PI3K inhibition caused apoptosis of nearly all osteoclasts in purified and co‐cultured marrow‐derived osteoclasts and spleen‐derived osteoclasts maintained with RANKL and M‐CSF. Interestingly, in marrow‐derived co‐cultures, the apoptotic response was restricted to osteoclasts as there was no evidence of stromal support cell apoptosis. PI3K inhibition also blocked MEK1/2, ERK1/2, and AKT phosphorylation and NFκB activation in purified osteoclasts. Simultaneous blockage of both AKT and MEK1/2 caused rapid apoptosis of nearly all osteoclasts, mimicking the response to PI3K inhibition. These data reveal that PI3K coordinately activates two distinct survival pathways that are both important in osteoclast survival. J. Cell. Biochem. 89: 165–179, 2003. © 2003 Wiley‐Liss, Inc.</description><subject>AKT</subject><subject>apoptosis</subject><subject>ERK</subject><subject>MEK</subject><subject>NFκB</subject><subject>osteoclast</subject><subject>PI3K</subject><issn>0730-2312</issn><issn>1097-4644</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNp1kD1OAzEQhS0EEuGn4AaukCiWjO39iUuIkgALAaEgSsvxOorBWYe1Q9ircQjOhCFARzGaN5rvveIhdETglADQ7pOaRpEB20IdArxI0jxNt1EHCgYJZYTuoj3vnwCAc0Y7aH03d345l8FUrTW18yY4i1nybGrpNVbONVWUQdsWSxXMa5Qeh7nGN4OyO7gvsawrfFZOuuPhx_s5XsowX8s2Ig4vpKlDHOx80E5Z6QP2q-Y1htgDtDOT1uvDn72PHoaDSf8iub4dXfbPrhPFWM6SSgHToAvoSU1nxZSmBQdOs3xKOcQnySogXKXTLB7A8hxSlvVmrCdTqaiq2D463uQuG_ey0j6IhfFKWytr7VZeEF5QwlkWwZMNqBrnfaNnYtmYhWxaQUB8VStiteK72sh2N-zaWN3-D4qr_vmvI9k4TKzi7c8hm2eRF6zIxON4JHh-X_YgLwWwT2lpisA</recordid><startdate>20030501</startdate><enddate>20030501</enddate><creator>Gingery, Anne</creator><creator>Bradley, Elizabeth</creator><creator>Shaw, Aubie</creator><creator>Oursler, Merry Jo</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope></search><sort><creationdate>20030501</creationdate><title>Phosphatidylinositol 3-kinase coordinately activates the MEK/ERK and AKT/NFκB pathways to maintain osteoclast survival</title><author>Gingery, Anne ; Bradley, Elizabeth ; Shaw, Aubie ; Oursler, Merry Jo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3363-dc03e0e708ae2f7b247909256b290dc015d019c4b5dc0036604358f38a4ac2cd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>AKT</topic><topic>apoptosis</topic><topic>ERK</topic><topic>MEK</topic><topic>NFκB</topic><topic>osteoclast</topic><topic>PI3K</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gingery, Anne</creatorcontrib><creatorcontrib>Bradley, Elizabeth</creatorcontrib><creatorcontrib>Shaw, Aubie</creatorcontrib><creatorcontrib>Oursler, Merry Jo</creatorcontrib><collection>Istex</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><jtitle>Journal of cellular biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gingery, Anne</au><au>Bradley, Elizabeth</au><au>Shaw, Aubie</au><au>Oursler, Merry Jo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Phosphatidylinositol 3-kinase coordinately activates the MEK/ERK and AKT/NFκB pathways to maintain osteoclast survival</atitle><jtitle>Journal of cellular biochemistry</jtitle><addtitle>J. Cell. Biochem</addtitle><date>2003-05-01</date><risdate>2003</risdate><volume>89</volume><issue>1</issue><spage>165</spage><epage>179</epage><pages>165-179</pages><issn>0730-2312</issn><eissn>1097-4644</eissn><abstract>We have examined highly purified osteoclasts that were generated in vitro from murine co‐culture of marrow precursors with stromal support cells and have found evidence of activation of the MEK/ERK and AKT/NFκB survival pathways. Many mature marrow‐derived osteoclasts survived for at least 48 h in culture whether or not they are maintained with stromal cells. Moreover, supplementing purified osteoclasts with RANKL and/or M‐CSF had no impact on their survival pattern. In addition, spleen‐derived osteoclasts generated with RANKL and M‐CSF treatment exhibited a similar survival pattern. Blocking MEK, AKT, or NFκB activity resulted in apoptosis of many, but not all, of the osteoclasts in purified marrow‐derived osteoclasts, marrow‐derived osteoclasts co‐cultured with stromal cells, and spleen‐derived osteoclasts maintained with RANKL and M‐CSF. These data support that both the MEK/ERK and AKT/NFκB pathways contribute to osteoclast survival. Since PI3K has been shown to activate either of these pathways, we have examined its role in osteoclast survival. PI3K inhibition caused apoptosis of nearly all osteoclasts in purified and co‐cultured marrow‐derived osteoclasts and spleen‐derived osteoclasts maintained with RANKL and M‐CSF. Interestingly, in marrow‐derived co‐cultures, the apoptotic response was restricted to osteoclasts as there was no evidence of stromal support cell apoptosis. PI3K inhibition also blocked MEK1/2, ERK1/2, and AKT phosphorylation and NFκB activation in purified osteoclasts. Simultaneous blockage of both AKT and MEK1/2 caused rapid apoptosis of nearly all osteoclasts, mimicking the response to PI3K inhibition. These data reveal that PI3K coordinately activates two distinct survival pathways that are both important in osteoclast survival. J. Cell. Biochem. 89: 165–179, 2003. © 2003 Wiley‐Liss, Inc.</abstract><cop>New York</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><doi>10.1002/jcb.10503</doi><tpages>15</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0730-2312 |
ispartof | Journal of cellular biochemistry, 2003-05, Vol.89 (1), p.165-179 |
issn | 0730-2312 1097-4644 |
language | eng |
recordid | cdi_proquest_miscellaneous_19721935 |
source | Wiley |
subjects | AKT apoptosis ERK MEK NFκB osteoclast PI3K |
title | Phosphatidylinositol 3-kinase coordinately activates the MEK/ERK and AKT/NFκB pathways to maintain osteoclast survival |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T20%3A33%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Phosphatidylinositol%203-kinase%20coordinately%20activates%20the%20MEK/ERK%20and%20AKT/NF%CE%BAB%20pathways%20to%20maintain%20osteoclast%20survival&rft.jtitle=Journal%20of%20cellular%20biochemistry&rft.au=Gingery,%20Anne&rft.date=2003-05-01&rft.volume=89&rft.issue=1&rft.spage=165&rft.epage=179&rft.pages=165-179&rft.issn=0730-2312&rft.eissn=1097-4644&rft_id=info:doi/10.1002/jcb.10503&rft_dat=%3Cproquest_cross%3E19721935%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3363-dc03e0e708ae2f7b247909256b290dc015d019c4b5dc0036604358f38a4ac2cd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=19721935&rft_id=info:pmid/&rfr_iscdi=true |